abgpharmaceuticals.in

  • No 44/22 Gundur, Bidarahalli, Bangalore
  • Mon - Fri : 09.00-17.00
Icon-facebook X-twitter Icon-linkedin Icon-instagram-1 Youtube
adi bilva pharmaceuticals private limited
Get in Touch

ABGRESS-HP™

Clarithromycin IP 500 mg + Esomeprazole IP 40 mg + Amoxicillin IP 1000 mg Tablets USP

  • Helicobacter pylori eradication therapy
  • Peptic ulcer disease associated with H. pylori
  • Prevention of H. pylori-associated ulcer recurrence following appropriate eradication therapy
Abpro-L

ABPRO-L™

Lactoferrin 100 mg + Bacillus Clausii 2 Billion CFU Capsules

  • Restoration of healthy intestinal microbiota
  • Support during antibiotic-associated gastrointestinal disturbance
  • Supportive management of digestive and gut-health requirements
ABPRO-10 Probiotics 10 Billion CFU by Adi Bilva Global Pharmaceuticals

ABPRO-10™

Probiotics 10 Billion CFU

  • Support of healthy intestinal microbiota
  • Support during antibiotic-associated bowel disturbance
  • General digestive and gut-health support
abalbu-hepa-protein-nutritional-powder.jpg Copy

ABALBU-HEPA™

Egg White Powder + L-Glutamine + L-Arginine + L-Leucine + L-Isoleucine + Multivitamin & Multimineral Powder

  • Nutritional support in patients with increased protein requirements
  • Dietary support in liver-related nutritional needs
  • Support for recovery and nutritional rehabilitation
ABPEG-PLUS Oral Solution Concentrate by Adi Bilva Global Pharmaceuticals

ABPEG-PLUS™

Polyethylene Glycol + Sodium Chloride + Sodium Bicarbonate + Potassium Chloride Concentrate for Oral Solution

  • Bowel cleansing before diagnostic procedures
  • Bowel preparation before colonoscopy
  • Bowel preparation before selected gastrointestinal procedures
ABRIFA-400/550 Rifaximin Tablets by Adi Bilva Global Pharmaceuticals

ABCHOLIC-300

Ursodeoxycholic Acid Sustained Release 300/450 mg Tablets

  • Cholestatic liver disorders where ursodeoxycholic acid is indicated
  • Primary biliary cholangitis
  • Selected gallstone-related conditions where medically appropriate
ABRIFA-400/550 Rifaximin Tablets by Adi Bilva Global Pharmaceuticals

ABCHOLIC-450

Ursodeoxycholic Acid Sustained Release 300/450 mg Tablets

  • Cholestatic liver disorders where ursodeoxycholic acid is indicated
  • Primary biliary cholangitis
  • Selected gallstone-related conditions where medically appropriate
ABGRESS-40/80 Esomeprazole Gastro-Resistant Capsules

ABGRESS-40

Esomeprazole Gastro-Resistant 40/80 mg Capsules

  • Gastroesophageal Reflux Disease (GERD)
  • Acid-related peptic disorders
  • Healing and maintenance of acid-related erosive esophageal conditions
ABGRESS-40/80 Esomeprazole Gastro-Resistant Capsules

ABGRESS-80

Esomeprazole Gastro-Resistant 40/80 mg Capsules

  • Gastroesophageal Reflux Disease (GERD)
  • Acid-related peptic disorders
  • Healing and maintenance of acid-related erosive esophageal conditions
ABRIFA-400/550 Rifaximin Tablets by Adi Bilva Global Pharmaceuticals

ABRIFA-400

Rifaximin 400mg Tablets

  • Hepatic encephalopathy recurrence-risk reduction
  • Irritable Bowel Syndrome with Diarrhea (IBS-D), where approved
  • Selected bacterial gastrointestinal infections, depending on formulation and local approval
ABRIFA-400/550 Rifaximin Tablets by Adi Bilva Global Pharmaceuticals

ABRIFA-550

Rifaximin 550 mg Tablets

  • Hepatic encephalopathy recurrence-risk reduction
  • Irritable Bowel Syndrome with Diarrhea (IBS-D), where approved
  • Selected bacterial gastrointestinal infections, depending on formulation and local approval
ABGRESS-D Esomeprazole and Domperidone Capsules

ABGRESS-D™

Esomeprazole Magnesium Trihydrate (EC) + Domperidone (SR) Capsules

  • Gastroesophageal Reflux Disease with associated symptoms
  • Acid-related dyspeptic symptoms
  • Reflux-associated gastrointestinal motility symptoms where clinically appropriate
ABPAN-C Pantoprazole and Cinitapride Capsules

ABPAN-C™

Pantoprazole Sodium (EC) + Cinitapride (SR) Capsules

  • Gastroesophageal Reflux Disease
  • Functional dyspepsia
  • Acid-related gastrointestinal symptoms with associated motility disturbance
ABGRESS-L Esomeprazole and Levosulpiride Capsules

ABGRESS-L™

Esomeprazole Magnesium Trihydrate (EC) + Levosulpiride (SR) Capsules

  • Gastroesophageal Reflux Disease
  • Functional dyspepsia
  • Acid-related gastrointestinal symptoms with associated motility disturbance
ABSAMe S-Adenosyl-L-Methionine Tablets

ABSAMe™

S-Adenosyl-L-Methionine Disulfate Tosylate Tablets

  • Selected cholestatic liver disorders
  • Supportive management of hepatic dysfunction where indicated
  • Intrahepatic cholestatic conditions under medical supervision
ABGRESS-IT Esomeprazole and Itopride Capsules

ABGRESS-IT™

Esomeprazole Magnesium Trihydrate (EC) + Itopride HCl (SR) Capsules

  • Gastroesophageal Reflux Disease
  • Functional dyspepsia
  • Acid-related symptoms associated with delayed gastric emptying/motility disturbance
ABMERZE L-Ornithine L-Aspartate and Nutritional Sachet

ABMERZE™

L-Ornithine L-Aspartate + Silymarin Extract + L-Glutathione + Calcium Pantothenate + Vitamins Sachet

  • Nutritional support in liver-health management
  • Supportive antioxidant supplementation
  • Nutritional support in selected hepatic conditions
ABGLUTA500 Glutathione 500 mg Tablets

ABGLUTA500™

Glutathione Tablets 500 mg

  • Antioxidant nutritional support
  • Supportive supplementation where glutathione support is appropriate
  • Nutritional support in conditions associated with oxidative stress
Featured Products Section

Explore our pharmaceutical portfolio across Gastro Care, 

featuring formulations developed for specialized healthcare segments.